On March 21, 2025 OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, reported that Paul Romness, CEO, and Gerald Commissiong, CBO will be accepting meetings with registered investors at The Jones Healthcare and Technology Innovation Conference (Press release, OS Therapies, MAR 21, 2025, View Source [SID1234651351]). The conference is being held on April 8-9, 2025 at the Venetian Resort in Las Vegas. The Company’s participation aligns with its prioritization of advancements in healthcare and technology while connecting with other investors.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Jones Healthcare and Technology Innovation Conference

Date: April 8-9, 2025

The conference is hosted by JonesTrading Institutional Services, LLC, a leading full-service investment banking firm providing a comprehensive suite of services, including capital markets, M&A, and strategic advisory to corporate clients. The event aims to bring together leading healthcare and technology companies, institutional investors, and opinion leaders to explore the latest trends and innovations shaping both industries. The conference will offer expert-led panels, corporate presentations, fireside chats, and one-on-one meetings covering advancements in healthcare and technology.